Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience

References

• Tariq NU, McNamara MG, Valle JW. Biliary tract cancers: current knowledge, clinical candidates and future challenges. CMAR. 2019;11:2623–2642.
   Web of Science ®Google Scholar
• Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39(S1):19–31.
   PubMed Web of Science ®Google Scholar
• Smittenaar CR, Petersen KA, Stewart K, et al. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115(9):1147–1155.
   PubMed Web of Science ®Google Scholar
• Njei B. Changing pattern of epidemiology in intrahepatic cholangiocarcinoma. Hepatology. 2014;60(3):1107–1108.
   PubMed Web of Science ®Google Scholar
• Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–1289.
   PubMed Web of Science ®Google Scholar
• Rizzo A, Frega G, Ricci AD, et al. Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: a systemic review and meta-analysis. In Vivo. 2020;34(2):479–488.
   PubMed Web of Science ®Google Scholar
• Adeva J, Sangro B, Salati M, et al. Medical treatment for cholangiocarcinoma. Liver Int. 2019;39(S1):123–142.
   PubMed Web of Science ®Google Scholar
• Sommer CM, Kauczor HU, Pereira PL. Locoregional therapies of cholangiocarcinoma. Visc Med. 2016;32(6):414–420.
   PubMed Web of Science ®Google Scholar
• Labib PL, Davidson BR, Sharma RA, et al. Locoregional therapies in cholangiocarcinoma. Hepat Oncol. 2017;4(4):99–109.
   PubMed Web of Science ®Google Scholar
• De Baere T, Deschamps F, Briggs P, et al. Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. Radiology. 2008;248(3):1056–1066.
   PubMed Web of Science ®Google Scholar
• Haidu M, Dobrozemsky G, Schullian P, et al. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study. Cardiovasc Intervent Radiol. 2012;35(5):1074–1082.
   PubMed Web of Science ®Google Scholar
• Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52–52.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Grassi CJ, Cardella JF, et al. Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;20(7):S377–S390.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. J Vasc Interv Radiol. 2014;25(11):1691–1705.e4.
   PubMed Web of Science ®Google Scholar
• Dhanasekaran R, Hemming AW, Zendejas I, et al. Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep. 2013; 29(4):1259–1267.
   PubMed Web of Science ®Google Scholar
• Ercolani G, Vetrone G, Grazi GL, et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252(1):107–114.
   PubMed Web of Science ®Google Scholar
• Chun YS, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729241.
   Web of Science ®Google Scholar
• Slakey DP. Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg. 2002;68(4):395–397.
   PubMed Web of Science ®Google Scholar
• Lee MW, Raman SS, Asvadi NH, et al. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: a 10-year intention-to-treat analysis. Hepatology. 2017;65(6):1979–1990.
   PubMed Web of Science ®Google Scholar
• Kulik L, Heimbach JK, Zaiem F, et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysis. Hepatology. 2018;67(1):381–400.
   PubMed Web of Science ®Google Scholar
• Sweeney J, Parikh N, El-Haddad G, et al. Ablation of intrahepatic cholangiocarcinoma. Semin Intervent Radiol. 2019;36(04):298–302.
   PubMed Web of Science ®Google Scholar
• Cho YK, Kim JK, Kim MY, et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49(2):453–459.
   PubMed Web of Science ®Google Scholar
• Serra C, Cucchetti A, Felicani C, et al. Assessment of radiofrequency ablation efficacy for hepatocellular carcinoma by histology and pre-transplant radiology. Liver Transpl. 2019;25(1):88–97.
   PubMed Web of Science ®Google Scholar
• Magistri P, Tarantino G, Ballarin R, et al. The evolving role of local treatments for HCC in the third millennium. AR. 2017;37(2):389–401.
   Web of Science ®Google Scholar
• Carrafiello G, Lagana D, Cotta E, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol. 2010;33(4):835–839.
   PubMed Web of Science ®Google Scholar
• Kim JH, Won HJ, Shin YM, et al. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol. 2011;196(2):W205–W209.
   PubMed Web of Science ®Google Scholar
• Fu Y, Yang W, Wu W, et al. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol. 2012;23(5):642–649.
   PubMed Web of Science ®Google Scholar
• Butros SR, Shenoy-Bhangle A, Mueller PR, Arellano RS. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control and long-term outcome. Clin Imaging. 2014;38(4):490–494.
   PubMed Web of Science ®Google Scholar
• Kim JH, Won HJ, Shin YM, et al. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Eur J Radiol. 2011;80(3):e221–e225.
   PubMed Web of Science ®Google Scholar
• Han K, Ko HK, Kim KW, et al. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis. J Vasc Interv Radiol. 2015;26(7):943–948.
   PubMed Web of Science ®Google Scholar